Literature DB >> 308614

Systemic membrane defect in the proximal muscular dystrophies.

N A Pickard, H D Gruemer, H L Verrill, E R Isaacs, M Robinow, W E Nance, E C Myers, B Goldsmith.   

Abstract

We studied lymphocyte capping in 61 patients with Duchenne, Becker, limb-girdle, facioscapulohumeral and congenital muscular dystrophies. All showed a markedly diminished percentage of capped cells when compared with 86 normal controls, providing support for previous evidence that an alteration in membrane fluidity may be a common pathogenic feature in several genetically distinct forms of proximal muscular dystrophy. Heterozygous carriers of Duchenne muscular dystrophy showed diminished capping that was indistinguishable from that of afflicted males and was often present even when serum enzyme levels were normal. Studies in 25 families with 16 suspected sporadic cases indicated that no more than four out of 30 afflicted males may represent new mutations. These findings imply that most cases of Duchenne dystrophy might be prevented by a population screening program for carrier females combined with prenatal detection of afflicted males.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 308614     DOI: 10.1056/NEJM197810192991601

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  25 in total

1.  Failure to demonstrate abnormal lymphocyte capping in humans, mice and hamsters with muscular dystrophy.

Authors:  M E Gershwin; R G Taylor; W M Fowler; B Finlayson
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  Sporadic cases in Duchenne muscular dystrophy. A reappraisal through segregation analysis on 988 sibships.

Authors:  A Russo; G Barbujani; M L Mostacciuolo; F H Herrmann; A W Spiegler; G Galluzzi; G A Danieli
Journal:  Hum Genet       Date:  1987-07       Impact factor: 4.132

Review 3.  Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.

Authors:  H Moser
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

4.  Lymphocyte capping in myotonic dystrophy.

Authors:  G L Walker; U Karagol; E C Mathieson; R J Lane; F L Mastaglia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-01       Impact factor: 10.154

5.  Facioscapulohumeral muscular dystrophy concentrated in the village Cullar, Nevşehir, Turkey.

Authors:  B S Sayli; K Yaltkaya; S Cin
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

6.  Duchenne muscular dystrophy. Frequency of sporadic cases.

Authors:  G A Danieli; G Barbujani
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

7.  Impaired HLA capping capacity of peripheral blood lymphocytes in Duchenne muscular dystrophy.

Authors:  A Sensi; A Venturoli; S Traniello; M Lucci; C Vullo; C Conighi; P L Mattiuz; O R Båricordi
Journal:  J Med Genet       Date:  1984-06       Impact factor: 6.318

8.  Increased membrane permeability to chloride in Duchenne muscular dystrophy fibroblasts and its relationship to muscle function.

Authors:  C N Pato; M H Davis; M J Doughty; S H Bryant; E Gruenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

9.  A cell surface abnormality in Duchenne muscular dystrophy: intercellular adhesiveness of skin fibroblasts from patients and carriers.

Authors:  G E Jones; J A Witkowski
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

10.  Segregation analysis of 1885 DMD families: significant departure from the expected proportion of sporadic cases.

Authors:  G Barbujani; A Russo; G A Danieli; A W Spiegler; J Borkowska; I H Petrusewicz
Journal:  Hum Genet       Date:  1990-05       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.